Wechselwirkungen · Zyllt
Zyllt 75 mg film-coated tablets · Abschnitt 4.5 · PDF-Seite 8
HOS-121556 · Präparat HOS-095389
Apart from the specific medicinal product interaction information described above, interaction studies with clopidogrel and some medicinal products commonly administered in patients with atherothrombotic disease have not been performed. However, patients entered into clinical trials with clopidogrel received a variety of concomitant medicinal products including diuretics, beta blockers, ACEI, calcium antagonists, cholesterol lowering agents, coronary vasodilators, antidiabetic agents (including insulin), antiepileptic agents, and GPIIb/IIIa antagonists without evidence of clinically significant adverse interactions.
Originalpassage; keine automatisch abgeleitete Schwere, Häufigkeit oder Kausalität. Auch verneinte Befunde und nicht untersuchte Kombinationen bleiben sichtbar.
RxNorm-Namen im Text (wörtliche Treffer, Rolle nicht bewertet): calcium (HOS-085615) clopidogrel (HOS-087927) cholesterol (HOS-087961)
Vollständigen Kontext in der EMA-Fachinformation lesen →Quellennachweis
Version 2025-05-14T12:07:00Z · SHA-256 f7bf5ef29f88fd676dd0507812419bb944fe4584c2c7bb6fde3ba14cc8084d6f · Passage 7d4f66c1e9e20aaefc05b48193a27de8f32c87b4363f5f9451600341e96458ac · Zeichen 7978–8601 im Abschnitt